The identification of five significant genes—TAC1, SOST, KCNA2, MUC1, and RGS1—as predictive markers highlights their potential utility in improving diagnostic precision and patient stratification in MMD [24]. This evidence concerns the gene MUC1 and multiminicore myopathy.